Michael. T. Alkire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael. T. Alkire has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Nathan S. White
Staff Research Associate
5 shared publicationsLarry Cahill
Department of Neurobiology and Behavior
3 shared publicationsRichard J. Haier
Professor in Residence, Department of Pediatrics
3 shared publicationsEmily L. Hahn
Staff Research Associate, Department of Anesthesiology
2 shared publicationsJames H. Fallon
2 shared publicationsJason Miller
Department of Anesthesiology, University of California at Irvine, Orange, CA 92868; and
2 shared publications
Latest Publications
- 1 September 2014
- Published by Elsevier in Neuroscience
- Vol. 277, 267-272
Glucocorticoids interact with noradrenergic activation at encoding to enhance long-term memory for emotional material in women
- 1 September 2014
- Published by Elsevier in Neuroscience
- Vol. 277, 267-272
Glucocorticoids interact with noradrenergic activation at encoding to enhance long-term memory for emotional material in women
- 10 June 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (supplement) , 10357-10364
Evolution of consciousness: Phylogeny, ontogeny, and emergence from general anesthesia
Are animals conscious? If so, when did consciousness evolve? We address these long-standing and essential questions using a modern neuroscientific approach that draws on diverse fields such as consciousness studies, evolutionary neurobiology, animal psychology, and anesthesiology. We propose that the stepwise emergence from general anesthesia can serve as a reproducible model to study the evolution of consciousness across various species and use current data from anesthesiology to shed light on the phylogeny of consciousness. Ultimately, we conclude that the neurobiological structure of the vertebrate central nervous system is evolutionarily ancient and highly conserved across species and that the basic neurophysiologic mechanisms supporting consciousness in humans are found at the earliest points of vertebrate brain evolution. Thus, in agreement with Darwin’s insight and the recent “Cambridge Declaration on Consciousness in Non-Human Animals,” a review of modern scientific data suggests that the differences between species in terms of the ability to experience the world is one of degree and not kind.
- 10 June 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (supplement) , 10357-10364
Evolution of consciousness: Phylogeny, ontogeny, and emergence from general anesthesia
Are animals conscious? If so, when did consciousness evolve? We address these long-standing and essential questions using a modern neuroscientific approach that draws on diverse fields such as consciousness studies, evolutionary neurobiology, animal psychology, and anesthesiology. We propose that the stepwise emergence from general anesthesia can serve as a reproducible model to study the evolution of consciousness across various species and use current data from anesthesiology to shed light on the phylogeny of consciousness. Ultimately, we conclude that the neurobiological structure of the vertebrate central nervous system is evolutionarily ancient and highly conserved across species and that the basic neurophysiologic mechanisms supporting consciousness in humans are found at the earliest points of vertebrate brain evolution. Thus, in agreement with Darwin’s insight and the recent “Cambridge Declaration on Consciousness in Non-Human Animals,” a review of modern scientific data suggests that the differences between species in terms of the ability to experience the world is one of degree and not kind.
- Open Access
- 1 November 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (5) , 981-995
Event-related Functional Magnetic Resonance Imaging of a Low Dose of Dexmedetomidine that Impairs Long-term Memory
Background: Work suggests the amnesia from dexmedetomidine (an α2-adrenergic agonist) is caused by a failure of information to be encoded into long-term memory and that dexmedetomidine might differentially affect memory for emotionally arousing material. We investigated these issues in humans using event-related neuroimaging to reveal alterations in brain activity and subsequent memory effects associated with drug exposure. Methods: Forty-eight healthy volunteers received a computer-controlled infusion of either placebo or low-dose dexmedetomidine (target = 0.15 ng/ml plasma) during neuroimaging while they viewed and rated 80 emotionally arousing (e.g., graphic war wound) and 80 nonarousing neutral (e.g., cup) pictures for emotional arousal content. Long-term picture memory was tested 4 days later without neuroimaging. Imaging data were analyzed for drug effects, emotional processing differences, and memory-related changes with statistical parametric mapping-8. Results: Dexmedetomidine impaired overall (mean ± SEM) picture memory (placebo: 0.58 ± 0.03 vs. dexmedetomidine: 0.45 ± 0.03, P = 0.001), but did not differentially modulate memory as a function of item arousal. Arousing pictures were better remembered for both groups. Dexmedetomidine had regionally heterogeneous effects on brain activity, primarily decreasing it in the cortex and increasing it in thalamic and posterior hippocampal regions. Nevertheless, a single subsequent memory effect for item memory common to both groups was identified only in the left hippocampus/amygdala. Much of this effect was found to be larger for the placebo than dexmedetomidine group. Conclusion: Dexmedetomidine impaired long-term picture memory, but did not disproportionately block memory for emotionally arousing items. The memory impairment on dexmedetomidine corresponds with a weakened hippocampal subsequent memory effect.
- 1 November 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (5) , 981-995
Open AccessEvent-related Functional Magnetic Resonance Imaging of a Low Dose of Dexmedetomidine that Impairs Long-term Memory
Background: Work suggests the amnesia from dexmedetomidine (an α2-adrenergic agonist) is caused by a failure of information to be encoded into long-term memory and that dexmedetomidine might differentially affect memory for emotionally arousing material. We investigated these issues in humans using event-related neuroimaging to reveal alterations in brain activity and subsequent memory effects associated with drug exposure. Methods: Forty-eight healthy volunteers received a computer-controlled infusion of either placebo or low-dose dexmedetomidine (target = 0.15 ng/ml plasma) during neuroimaging while they viewed and rated 80 emotionally arousing (e.g., graphic war wound) and 80 nonarousing neutral (e.g., cup) pictures for emotional arousal content. Long-term picture memory was tested 4 days later without neuroimaging. Imaging data were analyzed for drug effects, emotional processing differences, and memory-related changes with statistical parametric mapping-8. Results: Dexmedetomidine impaired overall (mean ± SEM) picture memory (placebo: 0.58 ± 0.03 vs. dexmedetomidine: 0.45 ± 0.03, P = 0.001), but did not differentially modulate memory as a function of item arousal. Arousing pictures were better remembered for both groups. Dexmedetomidine had regionally heterogeneous effects on brain activity, primarily decreasing it in the cortex and increasing it in thalamic and posterior hippocampal regions. Nevertheless, a single subsequent memory effect for item memory common to both groups was identified only in the left hippocampus/amygdala. Much of this effect was found to be larger for the placebo than dexmedetomidine group. Conclusion: Dexmedetomidine impaired long-term picture memory, but did not disproportionately block memory for emotionally arousing items. The memory impairment on dexmedetomidine corresponds with a weakened hippocampal subsequent memory effect.
- 24 October 2009
- Published by Springer Nature
- p. 127-138
Anesthesia and the Thalamocortical System
- 1 April 2009
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 110 (4) , 766-773
Thalamic Microinfusion of Antibody to a Voltage-gated Potassium Channel Restores Consciousness during Anesthesia
POTASSIUM (K) channels play a major role in regulating tissue excitability. There are at least four different types of K channels that serve slightly different functions in the nervous system, including voltage-gated (Kv), calcium-activated (KCa), inward rectifying (Kir), and 2-pore (K2P) domain background leak channels.1 Many authors have suggested that K channels are involved in producing the effects of anesthesia.1–6 Much recent focus has been placed on distinguishing K2P channels as possible targets of anesthetic action,6,7 yet interactions with various other K channels like the Kv channels may also be important.2,3,8,9
- 1 April 2009
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 110 (4) , 766-773
Thalamic Microinfusion of Antibody to a Voltage-gated Potassium Channel Restores Consciousness during Anesthesia
POTASSIUM (K) channels play a major role in regulating tissue excitability. There are at least four different types of K channels that serve slightly different functions in the nervous system, including voltage-gated (Kv), calcium-activated (KCa), inward rectifying (Kir), and 2-pore (K2P) domain background leak channels.1 Many authors have suggested that K channels are involved in producing the effects of anesthesia.1–6 Much recent focus has been placed on distinguishing K2P channels as possible targets of anesthetic action,6,7 yet interactions with various other K channels like the Kv channels may also be important.2,3,8,9
- Open Access
- 1 November 2008
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 109 (5) , 768-770
Hypothesis
- 1 November 2008
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 109 (5) , 768-770
Open AccessHypothesis
- 5 February 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (5) , 1722-1727
Neuroimaging analysis of an anesthetic gas that blocks human emotional memory
It is hypothesized that emotional arousal modulates long-term memory consolidation through the amygdala. Gaseous anesthetic agents are among the most potent drugs that cause temporary amnesia, yet the effects of inhalational anesthesia on human emotional memory processing remain unknown. To study this, two experiments were performed with the commonly used inhalational anesthetic sevoflurane. In experiment 1, volunteers responded to a series of emotional and neutral slides while under various subanesthetic doses of sevoflurane or placebo (no anesthesia). One week later, a mnemonic boost for emotionally arousing stimuli was evident in the placebo, 0.1%, and 0.2% sevoflurane groups, as measured with a recognition test. However, the mnemonic boost was absent in subjects who received 0.25% sevoflurane. Subsequently, in experiment 2, glucose PET assessed brain-state-related activity of subjects exposed to 0.25% sevoflurane. Structural equation modeling of the PET data revealed that 0.25% sevoflurane suppressed amygdala to hippocampal effective connectivity. The behavioral results show that 0.25% sevoflurane blocks emotional memory, and connectivity results demonstrate that this dose of sevoflurane suppresses the effective influence of the amygdala. Collectively, the findings support the hypothesis that the amygdala mediates memory modulation by demonstrating that suppressed amygdala effectiveness equates with a loss of emotional memory.
- 5 February 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (5) , 1722-1727
Neuroimaging analysis of an anesthetic gas that blocks human emotional memory
It is hypothesized that emotional arousal modulates long-term memory consolidation through the amygdala. Gaseous anesthetic agents are among the most potent drugs that cause temporary amnesia, yet the effects of inhalational anesthesia on human emotional memory processing remain unknown. To study this, two experiments were performed with the commonly used inhalational anesthetic sevoflurane. In experiment 1, volunteers responded to a series of emotional and neutral slides while under various subanesthetic doses of sevoflurane or placebo (no anesthesia). One week later, a mnemonic boost for emotionally arousing stimuli was evident in the placebo, 0.1%, and 0.2% sevoflurane groups, as measured with a recognition test. However, the mnemonic boost was absent in subjects who received 0.25% sevoflurane. Subsequently, in experiment 2, glucose PET assessed brain-state-related activity of subjects exposed to 0.25% sevoflurane. Structural equation modeling of the PET data revealed that 0.25% sevoflurane suppressed amygdala to hippocampal effective connectivity. The behavioral results show that 0.25% sevoflurane blocks emotional memory, and connectivity results demonstrate that this dose of sevoflurane suppresses the effective influence of the amygdala. Collectively, the findings support the hypothesis that the amygdala mediates memory modulation by demonstrating that suppressed amygdala effectiveness equates with a loss of emotional memory.
- 1 January 2008
- Published by Wolters Kluwer Health in International Anesthesiology Clinics
- Vol. 46 (3) , 55-73
Loss of Effective Connectivity During General Anesthesia
- 1 January 2008
- Published by Wolters Kluwer Health in International Anesthesiology Clinics
- Vol. 46 (3) , 55-73
Loss of Effective Connectivity During General Anesthesia
- Open Access
- 1 April 2005
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 102 (4) , 754-760
Does the Amygdala Mediate Anesthetic-induced Amnesia?
Background: Amnesia for aversive events caused by benzodiazepines or propofol depends on the basolateral amygdala (BLA). Whether the amnesia of volatile anesthesia is also mediated through the BLA is unknown. If so, a general principle of anesthetic-induced amnesia may be emerging. Here, using an inhibitory avoidance paradigm, the authors determine whether BLA lesions prevent sevoflurane-induced amnesia. Methods: Male Sprague-Dawley rats were separated into two groups: sham-operated controls (n = 22) and rats given bilateral N-methyl-D-aspartate lesions of the BLA (n = 32). After a 1-week recovery, the rats were randomly assigned to be trained during either air or sevoflurane (0.3% inspired, 0.14 minimum alveolar concentration) exposure. Animals learned to remain in the starting safe compartment of a step-through inhibitory avoidance apparatus for 100 consecutive seconds by administering foot shock (0.3 mA) whenever they entered an adjacent shock compartment. Memory was assessed at 24 h. Longer latencies to enter the shock compartment at 24 h imply better memory. Results: Sham-air (n = 10) animals had a robust memory, with a median retention latency of 507 s (interquartile range, 270-600 s). Sham-sevoflurane (n = 6) animals were amnesic, with a latency of 52 s (27-120 s) (P < 0.01, vs. sham-air). Both the air-exposed (n = 5) and the sevoflurane-exposed (n = 8) animals with BLA lesions showed robust memory, with latencies of 350 s (300-590 s) and 378 s (363-488 s), respectively. The latencies for both did not differ from the performance of the sham-air group and were significantly greater than the latency of the sham-sevoflurane group (both P < 0.01). Conclusions: BLA lesions block sevoflurane-induced amnesia. A role for the BLA in mediating anesthetic-induced amnesia may be a general principle of anesthetic action.
- 1 April 2005
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 102 (4) , 754-760
Open AccessDoes the Amygdala Mediate Anesthetic-induced Amnesia?
Background: Amnesia for aversive events caused by benzodiazepines or propofol depends on the basolateral amygdala (BLA). Whether the amnesia of volatile anesthesia is also mediated through the BLA is unknown. If so, a general principle of anesthetic-induced amnesia may be emerging. Here, using an inhibitory avoidance paradigm, the authors determine whether BLA lesions prevent sevoflurane-induced amnesia. Methods: Male Sprague-Dawley rats were separated into two groups: sham-operated controls (n = 22) and rats given bilateral N-methyl-D-aspartate lesions of the BLA (n = 32). After a 1-week recovery, the rats were randomly assigned to be trained during either air or sevoflurane (0.3% inspired, 0.14 minimum alveolar concentration) exposure. Animals learned to remain in the starting safe compartment of a step-through inhibitory avoidance apparatus for 100 consecutive seconds by administering foot shock (0.3 mA) whenever they entered an adjacent shock compartment. Memory was assessed at 24 h. Longer latencies to enter the shock compartment at 24 h imply better memory. Results: Sham-air (n = 10) animals had a robust memory, with a median retention latency of 507 s (interquartile range, 270-600 s). Sham-sevoflurane (n = 6) animals were amnesic, with a latency of 52 s (27-120 s) (P < 0.01, vs. sham-air). Both the air-exposed (n = 5) and the sevoflurane-exposed (n = 8) animals with BLA lesions showed robust memory, with latencies of 350 s (300-590 s) and 378 s (363-488 s), respectively. The latencies for both did not differ from the performance of the sham-air group and were significantly greater than the latency of the sham-sevoflurane group (both P < 0.01). Conclusions: BLA lesions block sevoflurane-induced amnesia. A role for the BLA in mediating anesthetic-induced amnesia may be a general principle of anesthetic action.
- 1 January 2005
- Published by Elsevier
- Vol. 150, 229-597
General anesthesia and the neural correlates of consciousness
- 1 January 2005
- Published by Elsevier
- Vol. 150, 229-597
General anesthesia and the neural correlates of consciousness